Reneo Pharmaceuticals has been added to the broad-market Russell 3000 Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, according to a preliminary list of additions posted May 19.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on RPHM:
- Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
- Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023
- Update — Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
- Insiders Pour $1 Million Each Into These 2 ‘Strong Buy’ Stocks — Here’s Why Wall Street Thinks They Could Double (or More)
- Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results